SCHEMBL6582877

SCHEMBL6582877

CCOC(=O)C(Cc1ccccc1)Oc1ccc2cc(-c3cc4ccccc4o3)ccc2c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.41
PPARA Q07869 1/20 0.41
PTPN1 P18031 7/20 0.41
MMP12 P39900 1/20 0.39
MMP13 P45452 1/20 0.39
MAPT P10636 2/20 0.39
HPGD P15428 2/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
TP53 P04637 1/20 0.39
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
PTPRC P08575 1/20 0.38
P2RY14 Q15391 1/20 0.38
TNKS O95271 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6579483 0.80 PPARA (0.43) PPARGPPARAPTPN1MAPTHPGD
SCHEMBL6579715 0.79 PTPN1 (0.50) PPARGPPARAPTPN1KDM4EMEN1
SCHEMBL11474239 0.72 AR (0.54) PPARGPPARAPTPN1MMP12MMP13
SCHEMBL6582637 0.72 PTPN1 (0.57) PPARGPPARAPTPN1
SCHEMBL6584826 0.72 PTPN1 (0.59) PPARGPPARAPTPN1PTPRCNPC1
SCHEMBL6581873 0.72 KDM4E (0.48) MAPTHPGDKDM4EALDH1A1TP53
SCHEMBL6582155 0.70 PTGES (0.41) PTPN1MAPTHPGDKDM4EALDH1A1
SCHEMBL9120247 0.69 PTGES (0.47) PPARGPPARAMAPTHPGDKDM4E
SCHEMBL11484559 0.69 LMNA (0.51) MMP12MMP13MAPTHPGDKDM4E
SCHEMBL6579501 0.69 PTPN1 (0.53) PPARGPPARAPTPN1PTPRCNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401822-A1 NAPHTHYL BENZOFURAN DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) Wyeth (US) 2004-03-31 EP disclosed
US-6599925-B2 Cardiovascular disorders; anticancer agents WYETH 2003-07-29 US disclosed
US-20030018067-A1 Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) WYETH 2003-01-23 US disclosed
WO-2003000671-A1 NAPHTHYL BENZOFURAN DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) WYETH (US) 2003-01-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030018067-A1 Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) F2R, SERPINE1, SERPINC1 PPARG 181/4885PPARA 218/4885PTPN1 1287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.